497 results
Page 2 of 25
8-K
zwny hhg0
22 Sep 22
Regulation FD Disclosure
4:02pm
8-K
EX-99.1
riu68pg
14 Sep 22
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
5:01pm
425
yhfibde998shlf 7oss
2 Sep 22
Business combination disclosure
4:01pm
8-K
da2sg29rn2gf
19 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:33pm
425
6s83qswrc84 kpw42ord
15 Aug 22
Business combination disclosure
6:46am
425
tiwm7469dvidhjnmbi3h
10 Aug 22
Business combination disclosure
8:08am
8-K
EX-99.1
h0mvl
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.3
1zw12bcx
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
xhs3pos
29 Jul 22
Prospectus supplement
4:06pm
425
p3s62i 6gx
6 Jul 22
Business combination disclosure
4:05pm
425
tq3 8d3vexuk1j0bwsak
9 Jun 22
Business combination disclosure
4:01pm
8-K
EX-99.2
mxpw8j i8aq8vqk
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
cvy4y
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
9j6ip2ydr74xejr
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am